US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
AMEX
Timber Pharmaceuticals Inc (TMBR)
Timber Pharmaceuticals Inc (TMBR) ニュース

TMBR

Timber Pharmaceuticals (TMBR)

Timber Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:TMBR

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/11/29	07 : 21	GlobeNewswire Inc.	Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/09/19	05 : 05	GlobeNewswire Inc.	Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/08/21	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals to be Acquired by LEO Pharma	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/07/04	05 : 05	GlobeNewswire Inc.	Timber Pharmaceuticals Discloses Communication From NYSE American	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/06/20	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/06/05	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/05/16	05 : 15	GlobeNewswire Inc.	Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/04/01	05 : 28	GlobeNewswire Inc.	Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/03/20	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology	AMEX:TMBR	Timber Pharmaceuticals Inc
2023/02/24	22 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/12/14	22 : 30	GlobeNewswire Inc.	Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/12/10	06 : 05	GlobeNewswire Inc.	Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/14	22 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/09	22 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/09	06 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/09	02 : 09	GlobeNewswire Inc.	Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/03	21 : 42	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/11/03	21 : 22	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Halt of Common Stock Trading	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/26	21 : 40	TipRanks	Analysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Timber Pharmaceuticals (TMBR)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/25	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/25	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/04	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/03	23 : 56	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/10/03	22 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Announces $1.3 Million Registered Direct Offering	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/09/14	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/09/13	05 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/09/03	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/08/30	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/08/30	05 : 05	GlobeNewswire Inc.	Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing Deficiency	AMEX:TMBR	Timber Pharmaceuticals Inc
2022/08/29	21 : 00	GlobeNewswire Inc.	Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress	AMEX:TMBR	Timber Pharmaceuticals Inc

Showing the most relevant articles for your search:AMEX:TMBR

1 2 3 4 5 6 7 次へ >>

Lyxor NYSE Arca Gold BUG...

Mtb Money Market Fund Institutio

Industrial Human Capital

Monitor Ventures

ALFA CONSORCIO PNF

Vontobel Financial Produ...

Battery Future Acquisition

Earle M Jorgensen

LEAGUE OF HEROES

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約